Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 4,311 | 713 | 13,842 | 13,759 | 13,682 |
| Operating Income | -4,311 | -713 | -13,842 | -13,759 | -13,682 |
| Interest Expense | 750 | 0 | 0 | 0 | 0 |
| Other Income | -1,578 | 0 | 30 | 105 | 28 |
| Pre-tax Income | -6,638 | -713 | -13,812 | -13,654 | -13,654 |
| Net Income Continuous | -6,638 | -713 | -13,812 | -13,654 | -13,654 |
| Net Income | $-6,638 | $-713 | $-13,812 | $-13,654 | $-13,654 |
| EPS Basic Total Ops | -0.11 | -0.12 | -0.52 | -0.51 | -0.54 |
| EPS Basic Continuous Ops | -0.11 | -0.12 | -0.52 | -0.51 | -0.54 |
| EPS Diluted Total Ops | -0.11 | -0.12 | -0.52 | -0.51 | -0.54 |
| EPS Diluted Continuous Ops | -0.11 | -0.12 | -0.52 | -0.51 | -0.54 |
| EBITDA(a) | $-3,504 | $-679 | $-13,833 | $-13,740 | $-13,662 |